A group of researchers including Antonio Giordano, M.D., Ph.D., Director and Founder of the Sbarro Health Research Organization (SHRO), Temple University, in collaboration with Stefano Landi, Ph.D.,. Chair of Genetics at University of Pisa, Italy, have identified potential novel drug candidates for the treatment of Malignant Pleural Mesothelioma (MPM). Study authors also include Federica Gemignani, Ph.D, Chair of Genetics at University of Pisa, Irene Dell'anno, Ph.D., University of Pisa, and Sarah A. Martin, PhD, Senior Lecturer at Barts Cancer Institute, London, UK.

(SHRO) Drug Repurposing Identifies New Candidates to Treat Mesothelioma

Newswise — A group of researchers including Antonio Giordano, M.D., …

(SHRO) Drug Repurposing Identifies New Candidates to Treat Mesothelioma Read More »